| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 01/02/2003 | EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/01/2003 | CN1388126A 吡咯并三嗪和嘧啶化合物 Pyrrolo-triazine and pyrimidine compounds |
| 01/01/2003 | CN1388118A Substituted phenyl alkyl nitrogen monoxide synthase inhibitor and its prepn and use |
| 01/01/2003 | CN1387905A Orally taken fracture setting Chinese medicine |
| 01/01/2003 | CN1387900A Medicine ointment for eliminating pain of bones and muscles |
| 01/01/2003 | CN1387888A Chinese medicine prepn for resisting osteoporosis |
| 01/01/2003 | CN1387885A Chinese medicine wine for treating rheumatism and arthralgia |
| 01/01/2003 | CN1387882A Chinese medicine prepn for treating cervical spondylopathy and its prepn process |
| 01/01/2003 | CN1387847A Lefunomide plaster and its prepn |
| 01/01/2003 | CN1387843A Medicine for preventing and treating osteoporosis |
| 01/01/2003 | CN1097588C Dihydrobenzofuran and related compounds used as anti-inflammatory agents |
| 01/01/2003 | CN1097587C Dihydrobenzofuran and related compound used as anti-inflammatory agent |
| 01/01/2003 | CN1097464C Chinese herbal medicine for treating cervical or lumbar vertebra diseases |
| 12/31/2002 | USRE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators |
| 12/31/2002 | US6500854 Chondrongenesis promotors and indolin-2-one derivatives |
| 12/31/2002 | US6500815 Bone disorders |
| 12/31/2002 | US6500811 Prophylaxis and therapy of disorders in the course of which an increased activity of matrix-degrading enzymes is involved; these include degenerative joint disorders such as osteoarthroses and disorders of connective tissue |
| 12/31/2002 | US6500804 Administering a dipeptidyl aminopeptidase effector which is selected from the group consisting of n-(n-substituted glycyl)2-cyanopyrrolidones, n-aminoacyl thiazolidines, n-aminoacyl pyrrolidines |
| 12/31/2002 | US6500641 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 12/31/2002 | US6500640 Nucleic acid molecules encoding modified dorsal tissue affecting factor |
| 12/31/2002 | US6500455 Coating crystalline, racemic tolperisone in coating column which is operated with air flow with mixture of methanol and solution of synthetic, semisynthetic or natural hydrogels in chloroform to produce delayed release preparation |
| 12/29/2002 | CA2392383A1 A complex comprising ocif and polysaccharide |
| 12/27/2002 | WO2002103031A2 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | WO2002103027A1 Glycoprotein and process for producing the same |
| 12/27/2002 | WO2002103014A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 12/27/2002 | WO2002102997A2 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/27/2002 | WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102800A1 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors |
| 12/27/2002 | WO2002102787A2 Novel sulfonic acid derivatives |
| 12/27/2002 | WO2002102783A1 Tyrosine kinase inhibitors |
| 12/27/2002 | WO2002102782A2 QUINAZOLINE DERIVATIVES which PROMOTE THE RELEASE OF PARATHYROID_HORMONE |
| 12/27/2002 | WO2002102778A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | WO2002102403A1 Mucosal repair by tff dimer peptides |
| 12/27/2002 | WO2002102399A2 Mucosal repair by tff2 peptides |
| 12/27/2002 | WO2002102396A1 Preventives or remedies for arthritis |
| 12/27/2002 | WO2002102394A2 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/27/2002 | WO2002102384A1 Antibacterial treatment of osteoarthritis |
| 12/27/2002 | WO2002102381A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 12/27/2002 | WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7 |
| 12/27/2002 | WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | WO2002102310A2 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | WO2002087626A9 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same |
| 12/27/2002 | WO2002083696A3 Novel cyclo azaphospha hydrocarbons |
| 12/27/2002 | WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain. |
| 12/27/2002 | WO2002060922A3 Epoxyvibsanin b |
| 12/27/2002 | WO2002056874A3 Lipid-based nitric oxide donors |
| 12/27/2002 | WO2002055099A3 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 12/27/2002 | WO2002055087B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 12/27/2002 | WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 12/27/2002 | WO2001085986A3 Phosphatidyl inositol 3-kinase delta binding partner |
| 12/27/2002 | WO2001080865A9 Joint repair using mesenchymal stem cells |
| 12/27/2002 | WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof |
| 12/27/2002 | CA2456685A1 Antibacterial treatment of osteoarthritis |
| 12/27/2002 | CA2451874A1 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 12/27/2002 | CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450809A1 Methods for detecting and treating the early onset of aging-related conditions |
| 12/27/2002 | CA2450793A1 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7 |
| 12/27/2002 | CA2450074A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 12/27/2002 | CA2450067A1 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | CA2449943A1 Preventives or remedies for arthritis |
| 12/27/2002 | CA2449898A1 Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 12/27/2002 | CA2448298A1 Phenylpyridine carbonyl piperazine derivative |
| 12/27/2002 | CA2430627A1 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/26/2002 | US20020198374 Steroids substituted at the 11 - position, process for their preparation, their use as medicament and the pharmaceutical compositions containing them |
| 12/26/2002 | US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 12/26/2002 | US20020198261 Liquid pharmaceutical compositions |
| 12/26/2002 | US20020198248 Therapeutic methods and compositions involving isoflavones |
| 12/26/2002 | US20020198242 Administering to an animal an effective dose of atleast an enzyme Dipeptidyl Peptidase (DP IV) enzyme activity effector to increase the capacity of insulin producing cells |
| 12/26/2002 | US20020198236 Small organic molecule regulators of cell proliferation |
| 12/26/2002 | US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions |
| 12/26/2002 | US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 12/26/2002 | US20020198194 Neuropeptide Y (NPY) antagonists for the treatment or prevention of arthritis, cardiovascular diseases, diabetes, renal failure, eating disorders, or obesity |
| 12/26/2002 | US20020198179 An estrogen or prodrug micture for reducing or eliminating the incidence of hot flashes and menopausal symptoms, while decreasing the risk of acquiring breast or endometrial cancer, inhibiting the development of osteoporosis |
| 12/26/2002 | US20020198177 Coenzyme Q and EPA |
| 12/26/2002 | US20020198154 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 12/26/2002 | US20020198143 B7-like polynucleotides, polypeptides, and antibodies |
| 12/26/2002 | US20020198142 Integrin inhibitors, for the treatment of disorders caused by implants, defects, inflammations and of osteolytic disorders such as osteoporosis, thrombosis, cardiac infarct and arteriosclerosis |
| 12/26/2002 | US20020197666 Human chordin-related proteins and polynucleotides encoding them |
| 12/26/2002 | US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof |
| 12/26/2002 | US20020197267 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 12/26/2002 | US20020197256 Combination therapy |
| 12/26/2002 | US20020197210 Stabilized therapeutic and imaging agents |
| 12/25/2002 | CN1387537A Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 12/25/2002 | CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors |
| 12/25/2002 | CN1387528A Heterocyclic substd, pyrazolones |
| 12/25/2002 | CN1387527A Qinazoline derivs. as VEGF inhibitors |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 12/25/2002 | CN1387431A Combination comprising beta 2 adranoreceptor agonist and lenkotriene receptor antagonist |
| 12/25/2002 | CN1386754A Non-T cell conjugating peptide and its use |
| 12/25/2002 | CN1386534A Powdered medicine for setting up bone, antalgic purpose and relaxing tendons |
| 12/25/2002 | CN1386533A Chinese medicine for treating simple hyperosteogeny and its preparing process |
| 12/25/2002 | CN1386515A Compound Chinese-medicinal capsule for treating arthritis |
| 12/25/2002 | CN1386514A Chinese medicine for treating rheumatic arthritis |